Get our free email newsletter

U.S. FDA Takes Steps to Ban Electroshock Therapy Devices

The U.S. Food and Drug Administration (FDA) has taken steps to end the use of certain electrical devices in treating patients manifesting aggressive or potentially self-injurious behaviors.

Under the terms of a Final Rule published in the Federal Register earlier this month, the FDA will ban the use of electrical stimulation devices (ESDs) in patient care and behavioral treatments. The ban takes effect in early April.

ESDs administer electrical shocks to patients through electrodes attached to their skin and are used to interrupt aggressive or potentially self-injurious behaviors. Although ESDs have been in use for more than 20 years, the FDA says that there is mounting evidence of the potentially harmful effects from the use of these devices, as well as advancements in medical science that are equally or more effective in treating patients without the harmful effects.

- Partner Content -

Shielding Effectiveness Test Guide

Just as interference testing requires RF enclosures, isolation systems in turn need their own testing. This document reviews some of the issues and considerations in testing RF enclosures.

According to the FDA, the only facility in the U.S. currently using ESDs in the treatment of patients and residents is a facility in Canton, MA, where an estimated 45-50 individuals are subject to treatments using ESDs.

Read the complete text of the FDA’s Final Rule in connection with ESDs as published in the Federal Register.

 

Related Articles

Digital Sponsors

Become a Sponsor

Discover new products, review technical whitepapers, read the latest compliance news, and check out trending engineering news.

Get our email updates

What's New

- From Our Sponsors -

Sign up for the In Compliance Email Newsletter

Discover new products, review technical whitepapers, read the latest compliance news, and trending engineering news.